Biotech News
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
ir.minervaneurosciences.com2026-05-06 15:16 EST
BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced the appointment of Dr.